IMMUNODIAGNOSTIC SYSTEMS
ActiveSummary
IMMUNODIAGNOSTIC SYSTEMS has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7.4m and a net result of €577,381. Equity is growing by about 3.9% per year across the filed financial years. Its solvency ranks better than 73% of 842 sector peers (NACE 73, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
3 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.